How To Be A Productive Pothead
Category: Culture | Posted on Sat, December, 7th 2013 by THCFinder
The most well known stereotype that stoners deal with is that we're lazy. We smoke too much bud to do anything but sit around and stare off in to space. Fortunately for us, that's not the truth anymore. Potheads have worked very hard in order to negate that stereotype and we have done a very good job of it. Stoners have managed to infiltrate almost every career path, from retail to engineering. Stoners work far harder than anyone at excelling because the bar has been set so high. No pun intended.
The first step to being a productive pothead is knowing how to handle yourself when you're sober and when you're stoned. Being able to function in both states of mind is key, although there are some people who are only able to function extremely well when they are high. You should be able to tell when you've smoked enough, whether or not you can handle being high at work, and if being stoned while on the job is safe for you and your coworkers. By knowing your limits and exhibiting self control, one can smoke and hold at job, while sometimes even excelling. It goes back to the very popular saying "If you're lazy when you smoke weed, you were lazy before you smoked".
To be a productive pothead, one must find something they love. Smoking is said to be a huge enlightenment on your mind, opening the smoker's eyes to new possibilities and scenarios. If you're stuck in a mundane job that you don't enjoy, smoking is going to make you dislike it even more. But if, every day, you make money by working at something that you really enjoy, the weed will only enhance that job and make being there better, as well as make the work you do better. And if you can't do what you love right now, start working towards it. It may take a while or it may take a few months but keeping yourself motivated is important.
Marijuana is a privilege. The plant should be used to make life better, rather than to hinder it. If you can't smoke and be productive, then you really shouldn't be smoking. Self control is extremely important, just as important as debunking the lazy stoner" stereotype. We are not lazy and it sure is offensive to be called as such. There are some stoners that work harder than any of the people around them, smokers and non smokers alike. Proving that we are productive and motivated will only further marijuana acceptance.
White Widow - Hybrid
Category: Nugs | Posted on Sat, December, 7th 2013 by THCFinder
FDA-approved medical marijuana clinical trial gets underway next month for kids with epilepsy
Category: Medical Marijuana | Posted on Sat, December, 7th 2013 by THCFinder
A nationally renowned pediatric neurologist at Saint Barnabas has gotten FDA approval to study whether a cannabis-based drug could prevent seizures in children diagnosed with severe forms of epilepsy.
The development is sure to be watched closely in New Jersey, where a number of families whose children have Dravet syndrome, a potentially deadly form of epilepsy, say they cannot obtain yet a useful form of medicinal marijuana through the state Department of Health.
The U.S. Food and Drug Administration gave Orrin Devinsky, director of the New York University and Saint Barnabas Comprehensive Epilepsy Center, Roberta Cilio of the University of California - San Francisco's Neurology Department, and GW Pharmaceuticals of the United Kingdom permission to use the experimental drug, Epidiolex, to treat 125 children with seizure disorders for whom traditional medicines have failed.
Enrollment in the trial will begin next month, Devinsky said.
"I think this is a big step forward in the science of Cannabidiods," said Devinsky, referring to the spectrum of active ingredients in marijuana. "We will finally get some some data on epilepsy, and this should provide the basis to plan a randomized double-blind study."
The drug is a liquid form of pure cannabidiol, a non-psychoactive component of the cannabis plant that according to anecdotal reports has shown to reduce the frequency and intensity of seizures in children. The FDA's Nov. 15th approval also gives Epidiolex "orphan drug" status, providing GW full marketing rights to be the lone producer of the product for seven years, the company said in a statement.
Orphan diseases are rare, occurring in less than 200,000 of people in the nation. There are 5,440 documented cases of Dravet syndrome in the United States and 6,710 in Europe, although the actual number may be higher because the condition is under-diagnosed, according to a statement from the pharmaceutical company. The seizures can damage the brain, delay development and cause lifelong intellectual disabilities.
Read more: http://www.nj.com
- 189,499 Views Category: Odd
- 148,984 Views Category: Fun
- 138,666 Views Category: Culture
- 98,344 Views Category: Culture
- 97,573 Views Category: Fun
- 96,995 Views Category: Culture
- 78,410 Views Category: Culture
- 76,527 Views Category: Odd
- 68,487 Views Category: Fun
- 61,304 Views Category: Fun